Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-12

Clinical Trial Update: Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure

View source ↗

Summary

A clinical trial investigating optic nerve head quantification during reduction of elevated intracranial pressure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Intraocular Pressure, Intracranial Hypertension | Status: WITHDRAWN